of novel benzene sulfonamides (previously evaluated as selective cyclooxygenase-2 inhibitors) has been profiled against human carbonic anhydrases I, II, IV and VII in an attempt to observe the manifestation of the well established "tail" approach for designing potent, isoform-selective inhibitors of carbonic anhydrases (CAs, EC 4.2.1.1). The compounds displayed an excellent (pKi 7-8) inhibitory profile
有人针对人类
碳酸酐酶I,II,IV和VII进行了一系列新颖的苯磺酰胺(先前被评估为选择性环氧合酶-2
抑制剂)的尝试,以观察建立有效的“尾巴”方法来设计有效的同工型的表现。 -
碳酸酐酶的选择性
抑制剂(CA,
EC 4.2.1.1)。这些化合物对CA II(胞质抗青光眼和抗
水肿
生物学靶标)和CA VII(也被认为与癫痫和神经性疼痛有关的胞质靶标)表现出出色的(pKi 7-8)抑制作用。 (1-2个数量级)对胞质同工型CA I和膜结合同工型CA IV的选择性。CA II和CA IV(两者都是催化活性同工型,